Similar articles

• Treatment of polycystic ovary patients undergoing IVF.

  Barri PN, Coroleu B, Martinez F, Traver JM, Veiga A, Calderon G. Barri PN, et al. J Assist Reprod Genet. 1997 Jan;14(1):10-2. doi: 10.1007/BF02765743. J Assist Reprod Genet. 1997. PMID: 9013302 Free PMC article. Review.
• In vitro fertilization treatment in patients with polycystic ovaries.

  Shulman A, Dor J. Shulman A, et al. J Assist Reprod Genet. 1997 Jan;14(1):7-10. doi: 10.1007/BF02765742. J Assist Reprod Genet. 1997. PMID: 9013301 Free PMC article. Review. No abstract available.
• The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.

  Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. Engmann L, et al. Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26. Fertil Steril. 2008. PMID: 17462639 Clinical Trial.
• The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

  Tarlatzis BC, Grimbizis G. Tarlatzis BC, et al. J Assist Reprod Genet. 1997 Jan;14(1):1-4. doi: 10.1007/BF02765740. J Assist Reprod Genet. 1997. PMID: 9013299 Free PMC article. Review.
• Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.

  Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER. Manzanares MA, et al. Fertil Steril. 2010 Mar 1;93(4):1215-9. doi: 10.1016/j.fertnstert.2008.12.019. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200978